5th Annual Pharma IPR Conference to Focus on Global Patents Laws
The 5th Annual Pharma IPR conference 2016, is on in Mumbai. The conference began on the 9th and will conclude today where leading experts from all over the world would be providing their distinctive perceptions on the Global Pharma Patent laws.
Organized by UBM, a leading exhibition organizer, the focus of the conference is to help people understand the intellectual property laws of the pharmaceutical industry of over 15 countries such as USA, Japan, Europe, Africa, India and Brazil.
The conference will also have case studies on the line of Pharma and Bio-Pharma patents. There would be panel discussions by leading experts from US on IP strategies for Complex Generics followed by a question and answer session.
Edward Pardon, a Partner at Merchant and Gould, one of US’s leading intellectual property firms spoke about the 101 patent ability decisions and their impact on treating the patents on a whole.
One of the highlights of the conference was the moot court session where a simulated court experience discussing the pharma patent litigation case laws were enacted. The conference provides an opportunity for people to come together from different countries and debate about the latest patent cases that has been making headlines across the globe.
Another highlight of the conference will be the panel discussion about Moving the Indian Pharma Industry to Innovations, where dignitaries from Panacea Biotec, MSF & Refry and Sagar would be its panel members.
Distinguished industry speakers like Alpesh Pathak – Global IP Head, Intas Pharmaceuticals Ltd. Leena Menghaney – Regional Head – South Asia, MSF – Access Campaign; Taranpreet Singh Lamba, Vice President – Intellectual Property Management, Glenmark Pharmaceuticals; Mandar Kodgule – Senior Vice President, Global IP & Corporate Strategy, Wockhardt Ltd.; Aaron F Barkoff – Shareholder, Mcandrews; Mahalaxmi Andheria – Vice President – Intellectual Property Cell, Panacea Biotec Ltd.; Dennies Varughese, Pharm.D. Director, Sterne Kessler Goldstein & Fox; Jonathan Atkinson – Partner, HGF; Paul A Braier, Ph.D. Esq – Partner, Greenblum & Bernstein, P.L.C., USA are some of the distinguished people who would be gracing the conference with their presence.
Organized by UBM, a leading exhibition organizer, the focus of the conference is to help people understand the intellectual property laws of the pharmaceutical industry of over 15 countries such as USA, Japan, Europe, Africa, India and Brazil.
The conference will also have case studies on the line of Pharma and Bio-Pharma patents. There would be panel discussions by leading experts from US on IP strategies for Complex Generics followed by a question and answer session.
Edward Pardon, a Partner at Merchant and Gould, one of US’s leading intellectual property firms spoke about the 101 patent ability decisions and their impact on treating the patents on a whole.
One of the highlights of the conference was the moot court session where a simulated court experience discussing the pharma patent litigation case laws were enacted. The conference provides an opportunity for people to come together from different countries and debate about the latest patent cases that has been making headlines across the globe.
Another highlight of the conference will be the panel discussion about Moving the Indian Pharma Industry to Innovations, where dignitaries from Panacea Biotec, MSF & Refry and Sagar would be its panel members.
Distinguished industry speakers like Alpesh Pathak – Global IP Head, Intas Pharmaceuticals Ltd. Leena Menghaney – Regional Head – South Asia, MSF – Access Campaign; Taranpreet Singh Lamba, Vice President – Intellectual Property Management, Glenmark Pharmaceuticals; Mandar Kodgule – Senior Vice President, Global IP & Corporate Strategy, Wockhardt Ltd.; Aaron F Barkoff – Shareholder, Mcandrews; Mahalaxmi Andheria – Vice President – Intellectual Property Cell, Panacea Biotec Ltd.; Dennies Varughese, Pharm.D. Director, Sterne Kessler Goldstein & Fox; Jonathan Atkinson – Partner, HGF; Paul A Braier, Ph.D. Esq – Partner, Greenblum & Bernstein, P.L.C., USA are some of the distinguished people who would be gracing the conference with their presence.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd